Skip to main content
Premium Trial:

Request an Annual Quote

Pfizer to Use GenoLogics Informatics Worldwide

NEW YORK (GenomeWeb news) – GenoLogics said today that Pfizer will license its lab and data management software under a three-year, global agreement.
 
Victoria, British Columbia-based GenoLogics said Pfizer will use its software suite to “capture, contextualize and integrate science data in multiple locations worldwide.”
 
The GenoLogics integrated software products are used for “managing biorepositories and clinical annotations to lab and data management systems for genomics, proteomics and other sciences,” the company said.
 
Pfizer’s Head of BBC Informatics, Giles Day, said that the GenoLogics software “can be customized at the lab level, including instrument integrations and data imports, while allowing us to analyze data across sciences and labs.”
 
Financial terms of the agreement were not released.

Filed under

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.